 Year over year, those trend lines increase. The percentage of prescriptions go up, the percentage of costs go down. That's probably good for the healthcare system to a degree, right up until we're at 100% of the scripts and 2% of the costs and we don't have a generic industry. So I actually think there's a lot of discussion between, let's say, the debate about manufacturers discussing with distributors and other frontline purchasers about how to further stabilize the generic industry.